Idiopathic pulmonary fibrosis is associated with endothelial to mesenchymal transition

American Journal of Respiratory Cell and Molecular Biology

Volumn 43, Issue 2, 2010, Pages 129-130

  Nataraj, Dilip ^a   Ernst, Armin ^b   Kalluri, Raghu ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BETA CATENIN; BETA GALACTOSIDASE; BIOLOGICAL MARKER; CALVASCULIN; CD31 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; RECOMBINANT OSTEOGENIC PROTEIN 1; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN; RAS PROTEIN;

BASEMENT MEMBRANE; CELL ADHESION; COMPETITIVE INHIBITION; DISEASE ASSOCIATION; EDITORIAL; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FIBROSING ALVEOLITIS; GENE EXPRESSION; HEART MUSCLE FIBROSIS; HEMATOPOIETIC STEM CELL; HUMAN; LUNG FIBROBLAST; LUNG PARENCHYMA; MESENCHYME CELL; METASTASIS; MORPHOLOGY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; BONE MARROW CELL; CYTOLOGY; CYTOSKELETON; DISEASE COURSE; ENDOTHELIUM; FIBROBLAST; FIBROSIS; GENE EXPRESSION REGULATION; LUNG FIBROSIS; MESODERM; METABOLISM; NOTE; PATHOLOGY; PATHOPHYSIOLOGY; STEM CELL;

ANIMALS; BONE MARROW CELLS; CYTOSKELETON; DISEASE PROGRESSION; ENDOTHELIUM; FIBROBLASTS; FIBROSIS; GENE EXPRESSION REGULATION; HUMANS; MESODERM; MODELS, BIOLOGICAL; PULMONARY FIBROSIS; RAS PROTEINS; SIGNAL TRANSDUCTION; STEM CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 77955483521     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2010-0044ED     Document Type: Editorial

References (14)

1. Raghu G, Freudenberger TD, Yang S, Curtis JR, Spada C, Hayes J, Sillery JK, Pope CE, Pellegrini CA. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J 2006; 27:136-142. (Pubitemid 43092677)
2. Taniguchi H, Ebina M, Kondoh Y, Ogura T, Azuma A, Suga M, Taguchi Y, Takahashi H, Nakata K, Sato A, et al. Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J 2010; 35:821-829.
3. Azuma A, Nukiwa T, Tsuboi E, Suga M, Abe S, Nakata K, Taguchi Y, Nagai S, Itoh H, Ohi M, et al. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2005;171:1040-1047. (Pubitemid 40616955)
4. Ramos C, Montano M, Garcia-Alvarez J, Ruiz V, Uhal BD, Selman M, Pardo A. Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression. Am J Respir Cell Mol Biol 2001;24:591-598. (Pubitemid 32442767)
5. Hashimoto N, Jin H, Liu T, Chensue SW, Phan SH. Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest 2004; 113:243-252. (Pubitemid 38544209)
6. Kim KK, Kugler MC, Wolters PJ, Robillard L, Galvez MG, Brumwell AN, Sheppard D, Chapman HA. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci USA 2006;103:13180-13185. (Pubitemid 44338936)
7. Willis BC, Liebler JM, Luby-Phelps K, Nicholson AG, Crandall ED, du Bois RM, Borok Z. Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am J Pathol 2005;166:1321-1332. (Pubitemid 40586504)
8. Zeisberg M, Kalluri R. The role of epithelial to mesenchymal transition in renal fibrosis. J Mol Med 2004;82:175-181. (Pubitemid 38392167)
9. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006;6:392-401.
10. Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, Chandraker A, Yuan X, Pu WT, Roberts AB, et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 2007;13:952-961. (Pubitemid 47222040)
11. Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, Kalluri R. Fibroblasts in kidney fibrosis emerge via endothelial to mesenchymal transition. J Am Soc Nephrol 2008;19:2282-2287.
12. Kim KK, Wei Y, Szekeres C, Kugler MC, Wolters PJ, Hill ML, Frank JA, Brumwell AN, Wheeler SE, Kreidberg JA, et al. Epithelial cell α3β1 integrin links β-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. J Clin Invest 2009;119:213-224.
13. Hashimoto N, Phan SH, Imaizumi K, Matsuo M, Nakashima H, Kawabe T, Shimokata K, Hasegawa Y. Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 2010;43:161-172.
14. Grunert S, Jechlinger M, Beug H. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat Rev Mol Cell Biol 2003;4:657-665. (Pubitemid 36934968)